Tag: COVID-19

April 19, 2022
FDA Authorizes Second COVID-19 Booster Dose for Special Populations

Adults aged 50 and older and immunocompromised individuals may receive a second booster dose.

READ MORE
February 19, 2022
FDA Fully Approves Moderna Vaccine & Expands Veklury’s Treatment Range

Drug advancements surrounding the prevention and treatment of COVID-19.

READ MORE
January 15, 2022
Additional Vaccine Candidate Performs Well in Clinical Trials

Phase 3 trials for NVX-CoV2373 across 30,000 people found this vaccine candidate to be safe and effective for the prevention of COVID-19.

READ MORE
January 14, 2022
CDC Updates Isolation and Quarantine Period for COVID-19

New five-day rules are recommended, with variation depending upon vaccination status.

READ MORE
December 20, 2021
COVID-19 Pill Approval and More Updates

Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.

READ MORE
December 19, 2021
The Long Haul: Chronic Health Complications of COVID-19

Those previously infected by the virus may face long-term health complications.

READ MORE
December 17, 2021
Federal Judges Try to Block Vaccine Mandates

Rulings from U.S. District Courts have impeded vaccine requirements among certain workers.

READ MORE
December 16, 2021
FDA Authorizes COVID-19 Booster Shots for All Adults

All adults may now receive a booster shot of any COVID-19 vaccine.

READ MORE
November 16, 2021
Sickness and Society: The Future of Infectious Disease in the Workplace

Strategies for a safer, healthier workforce amid COVID-19 and beyond.

READ MORE
November 15, 2021
FDA Authorizes Booster Shots for Moderna and J&J Vaccines

All COVID-19 vaccines now have emergency use authorization for a booster dose.

READ MORE
1 2 3 9
lockenvelopephone-handsetmenucross-circle